PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL-INDUCED LIVER INJURY COMPRISING (4S,5S)-5-FLUOROMETHYL-5-HYDROXY-4-((((5R)-5-ISOPROPYL-3-(ISOQUINOLIN-1-YL)-4,5-DIHYDRO-5-ISOXAZOLYL)CARBONYL)AMINO)-DIHYDROFURAN-2-ONE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

摘要

PURPOSE: A pharmaceutical composition for a liver damage treatment caused by alcohol is provided to effectively control apoptosis by reducing caspase at the liver damage caused by the alcohol. CONSTITUTION: A pharmaceutical composition for a liver damage treatment caused by alcohol contains CF1 marked as the chemical formula 1, or its pharmaceutically allowable salt. The liver damage caused by the alcohol includes fatty liver, alcoholic hepatitis, and alcoholic cirrhosis. CF1 is synthesized from the mixture of compounds marked as the chemical formula 6 and the chemical formula 7. The pharmaceutical composition is in a form of a tablet or a capsule.